These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 4767643

  • 1. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G, Venier A.
    Boll Chim Farm; 1973; 112(6):416-21. PubMed ID: 4767643
    [No Abstract] [Full Text] [Related]

  • 2. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR, Chodos DJ, Phillips JP, DeSante KA, Stoll RG.
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):220-7. PubMed ID: 950266
    [Abstract] [Full Text] [Related]

  • 3. [In vitro and in vivo investigations with different nitrofurantoin formulations (author's transl)].
    Gladigau V, Gebhardt U.
    Arzneimittelforschung; 1978 Apr; 28(10):1771-8. PubMed ID: 582682
    [Abstract] [Full Text] [Related]

  • 4. In vivo/in vitro correlation regarding nitrofurantoin tablets.
    Munoz Carnago E, Gonzales Porto E.
    Pharmazie; 1986 Apr; 41(4):290-1. PubMed ID: 3725877
    [No Abstract] [Full Text] [Related]

  • 5. A study of bioavailabilities and dissolution rates of commercial tablets of nitrofurantoin.
    McGilveray IJ, Mattok GL, Hossie RD.
    J Pharm Pharmacol; 1971 Dec; 23():246S. PubMed ID: 4401504
    [No Abstract] [Full Text] [Related]

  • 6. A disintegration test for evaluation of drug availability from tablets and capsules.
    Sandell E, Eriksson K, Mellström G.
    Acta Pharm Suec; 1970 Nov; 7(5):559-66. PubMed ID: 5275191
    [No Abstract] [Full Text] [Related]

  • 7. Biopharmaceutics of nitrofurantoin.
    Conklin JD.
    Pharmacology; 1972 Nov; 8(1):178-81. PubMed ID: 4644646
    [No Abstract] [Full Text] [Related]

  • 8. Proceedings: The comparison of the bioavailabilities of commercial nitrofurantoin tablets.
    McGilveray IJ, Mattok GL, Hossie RD.
    Rev Can Biol; 1973 Nov; 32():Suppl:99-106. PubMed ID: 4777608
    [No Abstract] [Full Text] [Related]

  • 9. Bioavailability of 14 nitrofurantoin products.
    Meyer MC, Slywka GW, Dann RE, Whyatt PL.
    J Pharm Sci; 1974 Nov; 63(11):1693-8. PubMed ID: 4427226
    [No Abstract] [Full Text] [Related]

  • 10. Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.
    Bates TR, Rosenberg HA, Tembo AV.
    J Pharm Sci; 1973 Dec; 62(12):2057-8. PubMed ID: 4762187
    [No Abstract] [Full Text] [Related]

  • 11. [Physiolical availability of medicinal agents in tablets and appraisal of their quality tests].
    Mikhaĭlova GS.
    Farmatsiia; 1974 Dec; 23(1):80-3. PubMed ID: 4817322
    [No Abstract] [Full Text] [Related]

  • 12. Dissolution, bioavailability and pharmacokinetics of three nitrofuratoin preparations in man.
    Bron J, Vree TB, Damsma JE, Hekster YA, van der Kleijn E.
    Arzneimittelforschung; 1979 Dec; 29(10):1614-20. PubMed ID: 42416
    [No Abstract] [Full Text] [Related]

  • 13. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I, Cadorniga R.
    Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139
    [No Abstract] [Full Text] [Related]

  • 14. In vitro comparison of the beaker, the rotating-basket and the column dissolution-rate methods.
    Bathe RV, Häfliger O, Langenbucher F, Schönleber D.
    Pharm Acta Helv; 1975 Feb; 50(1-2):3-10. PubMed ID: 1114160
    [No Abstract] [Full Text] [Related]

  • 15. [In vitro evaluation of biologic availability of solid peroral dosages].
    Ceschel GC, Duncan S, Dall'Olio G, Lupo C, Giani C.
    Boll Chim Farm; 1973 Oct; 112(10):645-64. PubMed ID: 4782260
    [No Abstract] [Full Text] [Related]

  • 16. Sustained release nitrofurantoin tablets by direct compression.
    Conte U, Colombo P, Caramella C, La Manna A.
    Farmaco Prat; 1979 Jul; 34(7):306-16. PubMed ID: 467625
    [No Abstract] [Full Text] [Related]

  • 17. pH-dependent dissolution rate of nitrofurantoin from commercial suspensions, tablets, and capsules.
    Bates TR, Young JM, Wu CM, Rosenberg HA.
    J Pharm Sci; 1974 Apr; 63(4):643-5. PubMed ID: 4828728
    [No Abstract] [Full Text] [Related]

  • 18. [Nitrofurantoin: dimensions of crystals and biologic availability].
    Borsa M, Bulletti GM, Zoni G.
    Boll Chim Farm; 1976 Jul; 115(7):483-8. PubMed ID: 1016604
    [No Abstract] [Full Text] [Related]

  • 19. Drug formulation and biologic availability.
    Poole JW.
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract] [Full Text] [Related]

  • 20. [Development of hardness and solution rate of tablets as a function of the compression force].
    Delonca H, Puech A, Youakim J, Segura G.
    J Pharm Belg; 1967 Sep; 22(5):209-12. PubMed ID: 5615275
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.